Antifibrotic treatments in other organs have led to studies that evaluated the efficacy of such treatments, for example, the expression of TGF-β in cultured pterygium fibroblasts has been inhibited, and a decrease in cell proliferation, migration, and collagen synthesis has been observed [39]. The gene discussed is TGFB1; the disease is pterygium.